AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Antidiabetic Effects and Other Health-Related Benefits of Dietary Fatty Acid

Summary: Purdue University researchers have developed a novel dietary fatty acid that has a similar biological effect to TZD. This dietary fatty acid significantly improved symptoms of diabetes in animal models including a 50 to 60 percent decline in plasma insulin, triglycerides, and free fatty acids.

Technology Benefits: Improved treatment of diabetes Insulin independent

Technology Application: Medical/Health Diabetes treatment

Detailed Technology Description: Martha BeluryPurdue Nutrition Science

Countries: United States

Application No.: 7,015,249

*Abstract

*Background: Thiazolidinediones (TZDs) are a class of oral insulin-sensitizing agents that improve glucose utilization without stimulating insulin release. The Parke-Davis drug Troglitazone(tm) is an example of a TZD currently being used for treating non-insulin dependent diabetes mellitus (NIDDM or type II diabetes mellitus).

*IP Issue Date: Mar 21, 2006

*IP Type: Utility

*Stage of Development: Concept validated through theory, simulation, or models

*Web Links: Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipMartha BeluryPurdue Nutrition Science

Country/Region: USA

For more information, please click Here